Podcast TCTMD Talking Points

PARTNER 2A: 5-Year Outcomes

C. Michael Gibson and Vinod Thourani discuss 5-year outcomes in this randomized trial of TAVR vs SAVR in intermediate-risk patients.

Talking Points · Episode 101: PARTNER 2A: 5-Year Outcomes

Listen to previous episodes | Download via iTunes

^{Brought to you by: Edwards Lifesciences}

TCTMD Talking Points

TCTMD Talking Points

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.